What are the criteria for diagnosing septic shock and the initial management steps?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Septic Shock Diagnosis and Initial Management

Diagnostic Criteria

Septic shock is diagnosed when a patient with sepsis requires vasopressors to maintain mean arterial pressure ≥65 mmHg AND has a serum lactate >2 mmol/L (>18 mg/dL) after adequate fluid resuscitation. 1, 2

Core Definition Components

  • Sepsis foundation: Life-threatening organ dysfunction caused by dysregulated host response to infection, operationalized as an increase in Sequential Organ Failure Assessment (SOFA) score of ≥2 points 2
  • Circulatory failure: Persistent hypotension requiring vasopressor therapy despite fluid resuscitation 1
  • Metabolic derangement: Elevated lactate >2 mmol/L indicating cellular/metabolic dysfunction 1, 2
  • Mortality threshold: This combination carries hospital mortality >40%, distinguishing septic shock from sepsis alone 1, 2

Rapid Bedside Screening (Out-of-Hospital/ED/Ward Settings)

Use quickSOFA (qSOFA) to identify patients at higher risk who need urgent evaluation—≥2 of the following criteria: 2

  • Respiratory rate ≥22/min
  • Altered mental status
  • Systolic blood pressure ≤100 mmHg

Important caveat: qSOFA is a screening tool for identifying high-risk patients, not a diagnostic criterion for septic shock itself. 2


Initial Management Steps

1. Immediate Recognition and Antimicrobials (Hour Zero)

Sepsis and septic shock are medical emergencies requiring immediate treatment. 3, 4, 5

  • Administer IV broad-spectrum antimicrobials within the first hour of recognizing septic shock to cover likely bacterial pathogens and possible fungal/viral organisms 4, 5
  • Obtain at least two sets of blood cultures (aerobic and anaerobic) before antibiotics, but never delay antimicrobial delivery if culture collection takes more than a few minutes 4, 5
  • For suspected Pseudomonas or multidrug-resistant organisms, initiate empiric combination therapy using two agents from different antibiotic classes 4

2. Fluid Resuscitation (First 3 Hours)

Deliver a minimum of 30 mL/kg of IV crystalloid fluid within the first 3 hours for sepsis-induced hypoperfusion. 3, 4, 5

  • Choose either normal saline or balanced crystalloids as the initial fluid—no superiority has been demonstrated between them 4, 5
  • Continue fluid administration while hemodynamic parameters improve (blood pressure, heart rate, mental status, capillary refill, urine output) 3, 4, 5
  • Add albumin when large volumes of crystalloids are required to maintain adequate mean arterial pressure 4, 5
  • Never use hydroxyethyl starches or gelatins—they increase acute kidney injury risk and mortality 4, 5

Critical reassessment principle: Perform frequent hemodynamic reassessments using thorough clinical examination and available physiologic variables to guide further fluid administration. 3, 5

3. Vasopressor Therapy

Initiate norepinephrine as the first-line vasopressor, targeting a mean arterial pressure (MAP) of 65 mmHg. 4, 5

Escalation algorithm when MAP target not achieved: 4, 5

  • Second agent: Add vasopressin at 0.03 units/min to norepinephrine
  • Third agent: Add epinephrine if hypotension persists despite norepinephrine and vasopressin
  • Avoid dopamine as first-line—norepinephrine provides superior outcomes; reserve dopamine only for highly selected patients with low risk of tachyarrhythmias and absolute/relative bradycardia 5

4. Hemodynamic Monitoring

Prefer dynamic variables over static measures to predict fluid responsiveness when available (e.g., pulse-pressure variation, stroke-volume variation). 3, 4, 5

  • Target lactate normalization as a marker of adequate tissue perfusion 3, 4, 5
  • Place an arterial catheter for continuous pressure monitoring in shock refractory to initial therapy or when vasopressors are required 5
  • Use bedside echocardiography as the first-line imaging modality to classify the type of shock 5

5. Source Control

Rapidly identify or exclude anatomic infection sources requiring emergent intervention. 4, 5

  • Implement source-control procedures (drainage, debridement) as soon as medically and logistically feasible after diagnosis 4, 5
  • Favor the least physiologically invasive intervention (e.g., percutaneous over surgical drainage) 4, 5
  • Promptly remove intravascular access devices that may be the infection source after establishing alternative vascular access 4, 5

6. Inotropic Support (If Needed)

Start dobutamine (up to 20 µg/kg/min) when myocardial dysfunction or ongoing hypoperfusion persists despite adequate volume and MAP. 5

  • Do not pursue supranormal cardiac index targets—aim for physiologic adequacy 5

Common Pitfalls to Avoid

  • Never delay antimicrobial therapy to obtain cultures—obtain cultures promptly but proceed with antibiotics immediately 4, 5
  • Avoid low-dose dopamine for renal protection—it offers no benefit and may cause harm 5
  • Prevent fluid overload by stopping fluid administration once hemodynamic improvement ceases—excess fluids worsen outcomes 5
  • Do not use hydroxyethyl starches or gelatins—strong contraindication due to increased mortality and acute kidney injury 4, 5

Resuscitation Targets Summary

  • MAP ≥65 mmHg 3, 5
  • Urine output ≥0.5 mL/kg/h 5
  • Lactate normalization in patients with elevated lactate 3, 5

Early Goals of Care Discussion

Discuss goals of care and prognosis with patients and families early, but no later than 72 hours after ICU admission. 3, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.